Vertex Pharmaceuticals Incorporated
VRTX
$552.85
$5.260.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.02% | 16.86% | 8.05% | -3.64% | 10.13% |
| Total Receivables | 12.72% | 10.58% | 27.55% | 11.18% | 14.33% |
| Inventory | 17.73% | 29.93% | 39.94% | 50.66% | 63.93% |
| Prepaid Expenses | 12.60% | 15.66% | 60.32% | 58.31% | 21.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 475.81% | -21.41% | -43.29% | 41.90% | -73.56% |
| Total Current Assets | 20.29% | 17.20% | 16.72% | 7.81% | 16.62% |
|
|
|||||
| Total Current Assets | 20.29% | 17.20% | 16.72% | 7.81% | 16.62% |
| Net Property, Plant & Equipment | 25.63% | 25.02% | 19.28% | 20.01% | 49.60% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -5.21% | -5.15% | -48.64% | -48.32% | -48.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.29% | 18.23% | 24.11% | 22.60% | 23.48% |
| Total Assets | 14.09% | 15.75% | 13.80% | 11.79% | 19.39% |
|
|
|||||
| Total Accounts Payable | -2.89% | 9.96% | 11.79% | 6.19% | 34.89% |
| Total Accrued Expenses | -2.80% | 1.10% | 7.67% | 12.23% | 11.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -10.29% | -- | -- |
| Total Finance Division Other Current Liabilities | -22.57% | 5.36% | 12.48% | 54.16% | 52.31% |
| Total Other Current Liabilities | -22.57% | 5.36% | 12.48% | 54.16% | 52.31% |
| Total Current Liabilities | -4.84% | 2.57% | 8.32% | 12.64% | 16.67% |
|
|
|||||
| Total Current Liabilities | -4.84% | 2.57% | 8.32% | 12.64% | 16.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 29.47% | 20.46% | 17.86% | 7.75% | 63.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.39% | 31.88% | 28.94% | 32.15% | 36.35% |
| Total Liabilities | 4.58% | 11.56% | 13.94% | 14.13% | 28.07% |
|
|
|||||
| Common Stock & APIC | -24.74% | -23.15% | -23.27% | -27.41% | -15.67% |
| Retained Earnings | 39.03% | 42.31% | 41.15% | 42.27% | 47.56% |
| Treasury Stock & Other | 147.97% | -63.58% | -112.44% | -323.96% | -549.33% |
| Total Common Equity | 17.89% | 17.37% | 13.75% | 10.80% | 16.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.89% | 17.37% | 13.75% | 10.80% | 16.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.89% | 17.37% | 13.75% | 10.80% | 16.25% |
|
|
|||||